资讯库
更紧凑的生命科学资讯库。
先搜索，再按来源或主题继续收窄。
罗氏Gazyva在自身免疫领域势头强劲，凭借三期试验胜利巩固狼疮治疗新阵地——Fierce Pharma报道
Roche's Gazyva, on an autoimmune hot streak, looks to further its new foothold in lupus with phase 3 win Fierce Pharma
罗氏应对关键药物动力减弱与第三季度汇率波动，但仍保持增长势头——激烈制药报道
Roche contends with loss of momentum for key medicines, currency fluctuations in Q3 but keeps growth on track Fierce Pharma
罗氏效仿同行，向美国制造与研发基地投入500亿美元——FirstWord Pharma
Roche follows peers with $50B investment in US manufacturing, research sites FirstWord Pharma